RNLXY

RENALYTIX PLC SP/ADR by Renalytix plc (RNLXY)

About RENALYTIX PLC SP/ADR by Renalytix plc (RNLXY)

Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.50
52 Week Low
$0.12
Market cap
29.8M
Dividend yield
0.00%
Volume
--
Avg. volume
45,572
P/E ratio
-.50

RENALYTIX PLC SP/ADR by Renalytix plc News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.50
52 Week Low
$0.12
Market cap
29.8M
Dividend yield
0.00%
Volume
--
Avg. volume
45,572
P/E ratio
-.50